Topics

BioTime, Inc. and Asterias Biotherapeutics, Inc. Company Profile

13:12 EDT 21st September 2019 | BioPortfolio

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are based on its pluripotent stem cell and dendritic cell immunotherapy technologies. Asterias is focused on developing therapies to treat conditions in several medical areas where there is high unmet medical need and inadequate available therapies. AST-OPC1 (oligodendrocyte progenitor cells) is currently in a Phase 1/2a dose escalation clinical trial in spinal cord injury. AST-VAC1 (antigen-presenting autologous dendritic cells) has demonstrated promise in a Phase 2 study in acute myelogenous leukemia. AST-VAC2 (antigen-presenting allogeneic dendritic cells) represents a second generation, allogeneic approach to dendritic cell vaccines. Additional information about Asterias can be found at www.asteriasbiotherapeutics.com.


News Articles [285 Associated News Articles listed on BioPortfolio]

BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias

ALAMEDA, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today provided a business update whic...

BioTime Announces Closing of Acquisition of Asterias Biotherapeutics Creating Leading Cell Therapy Company

Company Will Advance Three Clinical Stage Product Candidates Addressing Significant Unmet Needs in Dry-AMD, Spinal Cord Injury, and Immuno-Oncology BioTime, Inc....

BioTime doses first patient in OpRegen clinical study

BioTime said that it has dosed the first patent with the Orbit Subretinal Delivery System (Orbit SDS) along with with a new Thaw-and-Inject formulation of OpRegen, a retinal The post BioTime doses fi...

BioTime to Report Fourth Quarter and Full Year 2018 Financial Results on March 14th, 2019

BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will report its fourth quarter...

Evotec to acquire biologics company Just Biotherapeutics

Evotec has entered a definitive agreement to acquire Just Biotherapeutics and its in-house drug development technology platform J.DESIGN. Just Biotherapeutics provides machine-learning...Read More.....

Boehringer, Bridge Biotherapeutics sign licence agreement for IPF treatment candidate

The BBT-877 is Bridge Biotherapeutics’ autotaxin inhibitor being developed to treat various fibrosing interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF). Under the deal, Bridg...

BioTime to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019

BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing new cellular therapies, today announced that it will report its first quarter...

BioTime to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019

BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that it will report its second quarter 201...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (...

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (...

Atryn [gtc biotherapeutics, inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Winrho [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use WinRho SDF safely and effectively. See full prescribing information for WinRho SDF. WinRho SDF [Rho(D) Immune Globulin Intravenous (Hu...

Ixinity [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use IXINITY® safely and effectively. See full prescribing information for IXINITY.. IXINITY [coagulation factor IX (recombinant)] Lyophil...

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Six New Polyhydroxylated Steroids Conjugated with Taurine, Microdiscusols A-F, from the Arctic Starfish Asterias microdiscus.

Six new polyhydroxylated steroids conjugated with taurine, microdiscusols A-F, were isolated from the alcoholic extract of the Arctic starfish Asterias microdiscus. Three of them have been found to ha...

Characterization and prediction of positional 4-hydroxyproline and sulfotyrosine, two post-translational modifications that can occur at substantial levels in CHO cells-expressed biotherapeutics.

Biotherapeutics may contain a multitude of different post-translational modifications (PTMs) that need to be assessed and possibly monitored and controlled to ensure reproducible product quality. Duri...

Reliable LC-MS Multi-Attribute Method for Biotherapeutics by Run-Time Response Calibration.

A major challenge of a mass spectrometry-based quantitative multi-attribute method (MAM) for biotherapeutics is its high variability between instruments. For reproducible attribute measurements, not o...

Development and validation of a multiplexed drug level assay in support of combination biologics therapy clinical studies.

Clinical development of biotherapeutics for combination therapy requires monitoring the concentrations of both drugs in biological samples. Traditionally, two assays are required to measure drug level...

TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

Most immune responses to biotherapeutic proteins involve the development of anti-drug antibodies (ADAs). New drugs must undergo immunogenicity assessments to identify potential risks at early stages i...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

Investigation of the efficacy and safety of triflusal in comparison with aspirin in patients with stable coronary artery disease (CAD) and in those with a history of an acute non-cardioemb...

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

The Effect of OASIS Ultra on Critical Sized Wound Healing

The aim of this study is to evaluate the speed and quality with which OASIS® Ultra (Healthpoint Biotherapeutics; Fort Worth, Texas) increases wound healing in the critical sized defect. ...

Personalized Immunotherapeutics for Antibiotic-resistant Infection

M. A. suffers from hypogammaglobulinemia that has been complicated by refractory Mycoplasma hominis septic arthritis. He has been receiving the antibiotic valnemulin under Emergency Invest...

Companies [115 Associated Companies listed on BioPortfolio]

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are ba...

BioTime Inc.

BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime’s p...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...

BioTime, Inc. 

BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Company’s current clinical ...

BioTime, Inc.

BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell techn...

More Information about "BioTime, Inc. and Asterias Biotherapeutics, Inc." on BioPortfolio

We have published hundreds of BioTime, Inc. and Asterias Biotherapeutics, Inc. news stories on BioPortfolio along with dozens of BioTime, Inc. and Asterias Biotherapeutics, Inc. Clinical Trials and PubMed Articles about BioTime, Inc. and Asterias Biotherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioTime, Inc. and Asterias Biotherapeutics, Inc. Companies in our database. You can also find out about relevant BioTime, Inc. and Asterias Biotherapeutics, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record